Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1

Obesity Surgery

Volumn 21, Issue 9, 2011, Pages 1424-1431

  Liu, Yuan ^a   Zhou, Yong ^a   Wang, Yong ^a   Geng, Donghua ^a   Liu, Jingang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Glucagon like peptide 1 (GLP 1); Glucagon like peptide 1 receptor (GLP 1R); Roux en Y gastric bypass (RYGB); Type 2 diabetes mellitus (T2DM)

Indexed keywords

CASPASE 3; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DRUG HALF LIFE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ROUX Y ANASTOMOSIS; THERAPY EFFECT; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CELL LINE; DIABETES MELLITUS, TYPE 2; EATING; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; PEPTIDES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; VENOMS;

EID: 80052355207     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0388-z     Document Type: Article

References (20)

1. M Stumvoll BJ Goldstein TW van Haeften 2005 Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 9467 1333 1346 15823385 10.1016/S0140-6736(05)61032-X 1:CAS:528:DC%2BD2MXjtF2iu7g%3D
2. RA DeFronzo 1999 Pharmacologic therapy for type 2 diabetes mellitus Ann Intern Med 131 4 281 303 10454950 1:CAS:528:DyaK1MXlslehtb4%3D
3. PR Schauer, et al. 2003 Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 4 467 484 14530719 discussion 84-5
4. WJ Pories, et al. 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 3 339 350 7677463 10.1097/00000658-199509000-00011 1:STN:280:DyaK2Mvgsl2ltA%3D%3D discussion 350-2
5. F Rubino, et al. 2004 The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 2 236 242 15273546 10.1097/01.sla.0000133117.12646.48 (Pubitemid 38963013)
6. DE Cummings J Overduin KE Foster-Schubert 2004 Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution J Clin Endocrinol Metab 89 6 2608 2615 15181031 10.1210/jc.2004-0433 1:CAS:528: DC%2BD2cXmtlGqtLo%3D (Pubitemid 38766339)
7. S Mojsov, et al. 1986 Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing J Biol Chem 261 25 11880 11889 3528148 1:CAS:528:DyaL28XlsVOntr0%3D (Pubitemid 17206117)
8. ME Doyle JM Egan 2001 Glucagon-like peptide-1 Recent Prog Horm Res 56 377 399 11237222 10.1210/rp.56.1.377 1:CAS:528:DC%2BD3MXitV2ksr0%3D (Pubitemid 36068069)
9. DJ Drucker MA Nauck 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 9548 1696 1705 17098089 10.1016/S0140-6736(06)69705-5 1:CAS:528:DC%2BD28XhtF2gurjM (Pubitemid 46048557)
10. J Gerdes, et al. 1984 Cell cycle analysis of a cell proliferation- associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 4 1710 1715 6206131 1:STN:280:DyaL2c3ptVKgtA%3D%3D (Pubitemid 14035254)
11. I Marzo, et al. 1998 The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins J Exp Med 187 8 1261 1271 9547337 10.1084/jem.187.8.1261 1:CAS:528:DyaK1cXis1Cru7c%3D (Pubitemid 28189115)
12. TL Kindel, et al. 2009 Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism J Gastrointest Surg 13 10 1762 1772 19488823 10.1007/s11605-009-0912-9
13. J Korner, et al. 2005 Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin J Clin Endocrinol Metab 90 1 359 365 15483088 10.1210/jc.2004-1076 1:CAS:528:DC%2BD2MXlvFequw%3D%3D (Pubitemid 40116682)
14. J Korner, et al. 2006 Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels Obesity (Silver Spring) 14 9 1553 1561 10.1038/oby.2006.179 1:CAS:528:DC%2BD28Xht1WjsLzP (Pubitemid 46214822)
15. A Patriti, et al. 2004 The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery Obes Surg 14 6 840 848 15318993 10.1381/0960892041590818 (Pubitemid 38982273)
16. EE Mason 2005 The mechanisms of surgical treatment of type 2 diabetes Obes Surg 15 4 459 461 15946422 10.1381/0960892053723330 (Pubitemid 40605066)
17. WJ Pories RJ Albrecht 2001 Etiology of type II diabetes mellitus: role of the foregut World J Surg 25 4 527 531 11344408 10.1007/s002680020348 1:STN:280:DC%2BD3M3kt1eqtA%3D%3D (Pubitemid 32455209)
18. F Rubino M Gagner 2002 Potential of surgery for curing type 2 diabetes mellitus Ann Surg 236 5 554 559 12409659 10.1097/00000658-200211000-00003 (Pubitemid 35246885)
19. A Patriti, et al. 2005 Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model Obes Surg 15 9 1258 1264 16259883 10.1381/096089205774512573 (Pubitemid 41565122)
20. CF Deacon, et al. 1995 Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects Diabetes 44 9 1126 1131 7657039 10.2337/diabetes.44.9.1126 1:CAS:528:DyaK2MXotVGhu7c%3D